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The aim of this study was to characterize a collection of 95 Shigatoxin-producing E. coli 
(STEC). The five most common serogroups were O157, O145, O26, O103, and O146. Of the 
95 strains, 35 (36.8%) carried stx1 genes only, 43 strains (45.2%) carried stx2 and 17 (17.9%) 
harbored combinations of stx1 and stx2 genes. Stx1a (42 strains) and stx2a (32 strains) were the 
most frequently detected stx subtypes. Genes for intimin (eae), hemolysin (hly), iron-regulated 
adhesion (iha) and the subtilase cytotoxin subtypes subAB1, subAB2-1, subAB2-2 or subAB2-
3 were detected in 70.5%, 83.2%, 74.7% and 20% of the strains, respectively. Multilocus 
sequence typing assigned the majority (58.9%) of the isolates to five different clonal complexes 
(CC), 11, 32, 29, 20, and 165, respectively. CC11 included all O157:[H7] and O55:[H7] 
isolates. CC32 comprised O145:[H28] isolates, and O145:[H25] belonged to sequence type 
(ST) 342. CC29 contained isolates of the O26:[H11], O111:[H8] and O118:[Hnt] serotypes, 
and CC20 encompassed isolates of O51:H49/[Hnt] and O103:[H2]. CC165 included isolates 
typed O80:[H2]-ST301, all harboring stx2d, eae-, hly, and 66.7% additionally harboring iha. 
All O80:[H2]-ST301 strains harbored at least 7 genes carried by pS88, a plasmid associated 
with extraintestinal virulence. The detection of O80:[H2]-ST301 harboring stx2d, eae-, hly, 
iha, and pS88 related genes suggests an ongoing emergence in Switzerland of an unusual, 
highly pathogenic STEC serotype.  
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Ziel der Studie war die Charakterisierung von 95 Shigatoxin-bildenden E. coli Stämmen. Die 
Mehrheit der Stämme wurde den fünf Serogruppen O157, O145, O26, O103 und O146 
zugeordnet. Stx1 alleine wurde 35x (36.8%), stx2 43x (45.2%) nachgewiesen. Bei 17 Stämmen 
(17.9%) war die Kombination stx1 und stx2 vorhanden. Stx1a und stx2a waren die am 
häufigsten nachgewiesenen Subtypen. Intimin (eae), Hämolysin (hly), Iron-regulated Adhesion 
(iha) und die Subtilase-Cytotoxin-Subtypen subAB1, subAB2-1, subAB2-2 oder subAB2-3 
wurden in 70.5%, 83.2%, 74.7% und 20% der Stämme nachgewiesen. Mittels MLST wurde die 
Mehrheit (58.9%) der Isolate in fünf verschiedene CC eingeteilt, 11, 32, 29, 20 und 165. Alle 
O157:[H7] und O55:[H7] wurden dem CC11 zugeordnet. CC32 enthielt O145:[H28], und 
O145:[H25] Isolate wurden dem ST 342 zugeordnet. CC29 enthielt Isolate mit den Serotypen 
O26:[H11], O111:[H8] und O118:[Hnt], und CC20 umfasste Isolate von O51:H49/[Hnt] und 
O103:[H2]. CC165 enthielt O80:[H2]-ST301 Isolate, wobei alle die Kombination stx2d, eae-, 
hly hatten und 66.7% davon zusätzlich iha positiv waren. Alle O80:[H2]-ST301 enthielten 
mindestens 7 Gene, die sich auf dem Plasmid pS88 befinden, welches mit extraintestinaler 
Virulenz assoziiert ist. Der Nachweis von O80:[H2]-ST301 mit der Kombination stx2d, eae-, 
hly, iha und das Beherbergen von pS88 zugehörigen Genen, deutet auf die Ausbreitung eines 
ungewöhnlichen, hochpathogenen STEC Serotyps auch in der Schweiz hin. 
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Shiga toxin (Stx)-producing Escherichia coli (STEC) are important foodborne pathogens and 
responsible for outbreaks and sporadic cases of gastrointestinal illnesses which may include 
nonbloody or bloody diarrhea, hemorrhagic colitis (HC), and the hemolytic uremic syndrome 
(HUS) (Karch et al., 2005). Human pathogenic STEC produce one or more Stx, which consist 
of two groups designated Stx1 (consisting of the three variants Stx1a, Stx1c and Stx1d) and 
Stx2 (composed of seven distinct variants Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g). 
Among these variants, Stx2a, Stx2c and Stx2d are associated with severe disease and Stx2b and 
Stx2e are linked to mild clinical symptoms or asymptomatic fecal carriage (Stephan and 
Hoelzle, 2000; Friedrich et al., 2002; Fuller et al., 2011).  
Furthermore, STEC strains may feature additional virulence traits that influence their 
pathogenic potential, such as intimin, enterohemolysin, adhesin, and subtilase cytotoxin 
(SubAB), which are encoded by eae, hlyA, iha and subAB genes, respectively (Paton et al., 
2004; Johnson et al., 2006; Käppeli et al., 2011a). E. coli O157:H7 is the serotype most 
frequently associated with outbreaks and severe clinical outcomes and is to date reported as the 
most common STEC serotype in the European Union and in Switzerland (Käppeli et al., 2011b; 
EFSA, 2016). However, non-O157 STEC serogroups, in particular, O26, O103, O111, and 
O145, are also recognized for their pathogenic potential and constitute together with O157 the 
so called “top five” serogroups of human pathogenic STEC in the EU (Beutin, 2006; Johnson 
et al., 2006; EFSA, 2016). Beside this group of five, other STEC serogroups such as O91 and 
O121 have been associated with human illness in Germany and Switzerland, respectively 
(Mellmann et al., 2009; Käppeli et al., 2011a), and O45 and O121 are among the top seven 
serogroups detected in the U.S.A. (Gould et al., 2013). Changes in the Stx or serotype 
distribution of STEC infection is of public health significance as it may indicate the introduction 
of increasingly dominant strains. Identification of such strains is important as it may predict 
epidemiological changes or indicate novel sources of infection. 
The aim of the present study was therefore to characterize all STEC strains collected by the 
Swiss National Centre for Enteropathogenic Bacteria and Listeria (NENT, Zurich, Switzerland) 
during 2010-2014 and compare these results with earlier data from Switzerland investigated 





Materials and methods 
 
Strain collection 
A total of 95 Shigatoxin-producing Escherichia coli (STEC) strains isolated from human 
patients during 2010-2014 in Switzerland were characterized. The strain collection was 
obtained from the Swiss National Centre for Enteropathogenic Bacteria and Listeria (NENT). 
Forty-eight strains (50.5%) were from female and 47 strains (49.5%) from male patients. The 
median age was 24 years (range <1-79 years). Forty-one strains (43.2%) were isolated from 
patients ≤ 5 years of age. The strains had all been confirmed to possess stx genes (stx1 and/or 
stx2) by real-time PCR (LightCycler® 2.0 Instrument, Roche Diagnostics Corporation, 
Indianapolis, IN, USA), (EURL, 2013a). 
  
Serotyping 
Strains were examined by PCR for the presence of genes associated with 15 selected serogroups 
including the top-five serogroups, namely O26, O45, O51, O55, O80, O91, O103, O104, O111, 
O113, O121, O128, O145, O146, and O157 (Perelle et al., 2004; EURL, 2013a; EURL, 2013b; 
EURL, 2014; Soysal et al., 2016). 
Strains belonging to other O groups were serotyped at the National Reference Laboratory for 
Escherichia coli, Federal Institute for Risk Assessment, Berlin, Germany, using standard 
methods and O–specific rabbit antisera. H types were determined by PCR, except for O51:H49, 
which had been typed previously using standard methods (Fasel et al., 2014). Strains were 
tested for the presence of flagellar genes related to H2, H4, H7, H8, H10, H11, H19, H21, H25 
and H28 (Mora et al., 2012; EURL, 2013b; Beutin et al., 2015; Alonso et al., 2017).  
 
Virulence factor genes 
The determination of stx1 subtypes (stx1a, stx1c, stx1d) and stx2 subtypes (stx2a, stx2b, stx2c, 
stx2d, stx2e, stx2f, stx2g) was performed by conventional PCR amplification (Scheutz et al., 
2012). Furthermore, the strains were screened by conventional PCR for hlyA (Schmidt et al., 
1995), iha (Schmidt et al., 2001), and subAB (encoding SubAB), including its subAB subtypes 
(subAB1, subAB2-1, subAB2-2 and subAB2-3), as described previously (Tozzoli et al., 2010; 
Funk et al., 2013; Nüesch-Inderbinen et al., 2015; Müller et al., 2016; Tasara et al., 2017;), 
using primers listed in supplementary Table 1. Screening for eae, aggR coding for a 
transcriptional regulator in enteroaggregative E. coli (EAEC), and elt and estIa/Ib encoding 
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heat-labile and heat stabile enterotoxins in enterotoxigenic E. coli (ETEC) was performed by 
real-time PCR according to the guidelines of the European Union Reference laboratory (EURL, 
2013c). Identification of the eae variants 1, 2,1, 12/θ, 1, , η, 1,  and  was 
performed using primers described by Blanco et al. (Blanco et al., 2005). 
Strains belonging to O80:H2 were screened by PCR for the pS88 related genes sitA, cia, iss, 
iucC, iroN, hlyF, etsC, cvaA, and ompTp, using primers described by Peigne et al. (Peigne et 
al., 2009). 
 
Further characterization of E. coli O157 strains 
The collection of E. coli O157 strains was tested for sorbitol fermentation by using sorbitol 
MacConkey agar (SMAC) (Oxoid Ltd., Basingstoke, UK). All the E. coli O157 strains were 
analyzed by PCR for their flagellar (fliC) genotypes for fliCH7 as described previously (Gannon 
et al., 1997). The presence of O157 and the H7 antigen was corroborated with a latex 
agglutination test (Wellcolex™ E. coli O157:H7, Remel, USA). 
 
Multilocus sequence typing (MLST) 
MLST was performed by PCR amplification and sequencing of internal fragments of seven 
housekeeping genes (adk, fumC, gyrB, icdF, mdh, purA, recA) (Wirth et al., 2006). Alleles and 





Identification of serotypes 
Of the 95 STEC isolates, 78 (82.1%) were assigned to O types by PCR. Seventeen (17.9%) of 
the isolates did not fall into any of the serogroups tested for by PCR. Serological typing 
classified these strains into serogroups O46, O75, O76, O78, O80, O82, O84, O118, O156, 
O165, O166, O174, O177, O178, O183, ONT, and O rough (Table 1). An overview of the 
determined serotypes is given in Table 1. 
Among the 95 isolates, 18 (19%) were O157:[H7], and 77 (81%) were non-O157 STEC isolates. 
Of the non-O157 strains, O145:[H25/H28] was the most common (n=12/15.6% of all non-O157 
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isolates), followed by O26:[H11] (n=10/13%), O103:[H2] (n=10/13%), and O146:[H2/H21/H28] 
(n=8/10.4%). 
 
Detection of virulence genes 
Of the 95 STEC strains, 35 (36.8%) carried stx1 genes only: stx1a (n=28) and stx1c (n=7). 
Forty-three strains (45.2%) carried stx2 genes only: stx2a (n=18), stx2b (n=7), stx2c (n=4), 
stx2d (n=6), stx2e (n=1), and stx2a/stx2c (n=7). Seventeen strains (18%) harbored combinations 
of stx1 and stx2 genes. Forty-eight strains (50.5% of all isolates) carried the subtypes associated 
with high pathogenic potency, stx2a, stx2c, or stx2d (Table 1). The majority thereof 
(n=29/60.4% of the 48 strains) belonged to the top-five serogroups, predominantly to O157 
(n=17) and O145 (n=11), but notably, six (12.5%) belonged to serogroup O80. 
Twelve isolates harbored the low pathogenic subtypes stx2b and stx2e and were mainly 
associated to the serogroups O146 (n=6/ 50% of the 12 isolates), as shown in Table 1. None of 
the isolates harbored stx2f. 
Genes for intimin, enterohemolysin, iron-regulated adhesion and subtilase cytotoxin were 
detected in 67 strains (70.5% of all isolates), 79 strains (83.2%), 71 strains (74.7%), and 19 
strains (20%), respectively. The majority of the subAB harboring isolates (n=11/57.9%) was 
associated with stx2b (Table 1).  
The 67 eae positive isolates comprised six intimin variants including 1 (n=14/20.9% of the 67 
isolates), 1 (n=31/46.3%), and 1 (n=12/17.9%),(n=6/9%),(n=2/3%), 2/θ (n=1/1.5%) 
and one (1.5%) non-typeable (nt) strain (Table 1).  
Of the six O80:[H2]- strains, all (100%) carried pS88-related genes sitA, cia, iss, iroN, hlyF, 
cvaA, and ompTp, and five (83.3%) additionally had the iucC and the etsC genes (data not 
shown). 
All 95 STEC strains were negative for aggR, elt and estIa/Ib. 
 
Further characterization of the O157-positive strains  
Sixteen (88.9% of all O157-positive isolates) were non-sorbitol fermenters (nSF) on SMAC. 
Thereof, 11 were O157:H7 by latex agglutination. Two strains (11.1%) fermented sorbitol (SF), 
both were O157:H- by latex agglutination. However, all 18 strains tested positive for fliCH7 by 





Multilocus sequence typing 
An overview of the sequence types of the isolates is given in Table 1. 
MLST assigned the majority (58.9%) of the isolates to 5 different clonal complexes (CC): CC11 
(n=19), CC20 (n=12), CC29 (n=12), CC32 (n=7) and CC165 (n=6). 
Isolates of O serogroup O157 and O55 clustered in CC11. Isolates of O103 belonged to ST17 
or ST386 and were all found with O51, within CC20. Isolates of the serogroups O26 (ST21 and 
ST29), O111 (ST16) and O118 (ST21) clustered within CC29. Seven of the 12 O145 isolates 
clustered in CC32, whereas further five O145 isolates belonged to ST342 and were not assigned 




This study describes the serotypes, virulence genes and multilocus sequence types of STEC 
associated with human disease in Switzerland during 2010 and 2014. The five most common 
serogroups were O157, O145, O26, O103, and O146, with E. coli O157 accounting for 19% of 
the STEC-related infections. By comparison, during 2000 and 2009, 30.6% of the STEC strains 
isolated from clinical cases in Switzerland were STEC O157 (Käppeli et al., 2011b). Thus, as 
reported for other countries in the EU (ECDC, 2015), the proportion of non-O157 STEC 
associated with human STEC infections has increased also in Switzerland. 
We further observed a change with regard to the most common non-O157 serotypes reported 
for the time span of 2000–2009 in Switzerland, O26:H11, O103:H2, O121:H19 and 
O145:H28/H–), respectively (Käppeli et al., 2011a). Compared with the previous study period, 
infections due to STEC O121:[H19] decreased (from 6.2% to 1.3% of all non-O157 STEC 
infections), while those accounted for by STEC O146:H2/21 and STEC O146:H28 increased 
(from 0% to 3.9%, and 1% to 5.2%, respectively) during 2010-2014. Evaluation of the virulent 
characteristics of the STEC serotypes showed that the majority of the common serogroups 
O157, O145 and O26 harbored stx2a alone or in combination with stx1 or stx2c, and showed a 
consistent eae and hlyA gene pattern as described previously (Käppeli et al., 2011a; Käppeli et 
al., 2011b).  
Intimin 1 was detected most frequently in this study and was associated with the most 
frequent STEC strains O157:[H7| and O145:[H28/[H25], in agreement with previous 
observations for STEC from humans (Beutin et al., 2004). Similarly, intimin1 was found 
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predominantly in STEC O26:[H11] and intimin ε1 in O103:[H2] and O121:[H19] (Beutin et 
al., 2004). Notably, the rare intimin variant ξ was associated with serotype O80:[H2]. 
Of the five most common serogroups found in this study, STEC O146 was the only serogroup 
that lacked the eae gene, but contained subAB genes. Subtilase cytotoxin SubAB is an emerging 
pathogenic factor that it is not routinely searched for in isolates from patients with STEC 
infections. Among the 95 isolates analyzed in this study, 67.9% of the eae negative strains 
harbored one or more subAB subtypes, including the recently described subAB2-3 (Nüesch-
Inderbinen et al., 2015) and 42.1% of all subAB-positive strains were STEC O146. Whereas 
subAB1, subAB2-1 and subAB2-2 have been detected in clinical isolates elsewhere (Paton et 
al., 2004; Khaitan et al., 2007; Hoang Minh et al., 2015; Son et al., 2015), this is to our 
knowledge the only human clinical isolate harboring subAB2-3 described so far. Its genome 
sequence is available under GenBank accession number MPGQ00000000 (Tasara et al., 2017). 
Our results indicate that the presence of subAB among STEC associated with human disease 
may be currently underestimated. However, this study was limited by the lack of anamnestic 
data to allow a correlation of the presence of SubAB with severity of disease.  
The five most common serogroups in this study belonged to a limited number of CC and ST, 
whereas the vast majority of the remaining STEC strains were represented by a total of 28 STs, 
24 of which contained only a single isolate. CC11 comprised all the O157 STEC, including the 
SF strains, confirming high clonality of this serogroup as described previously (Bielaszewska 
et al., 2007; Kossow et al., 2016). Furthermore, this CC included an isolate belonging to O55, 
which is in accordance to its evolutionary relatedness to O157 (Bono et al., 2012). 
CC20 included all the O103 STEC analyzed in this study, indicating a monophyletic origin of 
these strains. MLST further demonstrated that O103 and O51 clustered together in CC20, 
suggesting clonal relationship of these isolates. 
Within CC29, only one of the isolates was O26:[H11]-ST29. STEC O26:[H11] belonging to 
this particular ST and harboring stx1a/stx2a or stx2a alone has been described as a virulent 
clone that emerged in Germany and has been circulating in Europe since the mid-1990ies 
(Bielaszewska et al., 2013). Whereas during 2000-2009, O26:H11-ST29 harboring stx1a/stx2a 
or stx2a alone was detected in 11.3% of human infections due to STEC in Switzerland (Käppeli 
et al., 2011a; Zweifel et al., 2013), in the time span 2000-2014 only one such strain (1.1% of 
all isolates) was isolated, suggesting a decline of the highly virulent German clone in 
Switzerland over the last decade. On the other hand, the percentage of STEC O26:[H11]-ST21, 
which during 2000 and 2009 accounted for 57.1% of the STEC O26 infections, increased to 
90% for the time span under observation. This phenomenon has public health relevance, since 
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all (100%) of the STEC O26:[H11]-ST21 harbored stx1a, which is associated with milder 
course of disease. Multilocus sequence typing further revealed that isolates of O26, O111 and 
O118 clustered together in the same CC, indicating close relationship of these serogroups, as 
established previously (Ju et al., 2012; DebRoy et al., 2016). 
CC32 contained seven isolates of the serogroup O145 ST32. In contrast, five further O145 
isolates were ST342, which differs in its allelic profile in all loci from ST32. This indicates that 
the STEC O145 isolates originate from different clonal sources. Isolates belonging to STEC 
O146 fell into two major STs (442 and 738, respectively), neither of which were allocated to a 
particular CC. 
Finally, 6.3% of the isolates analyzed in this study typed O80:[H2]-ST301 and clustered within 
CC165. All these isolates (100%) harbored stx2 (stx2a or stx2d), eae-ξ, and hlyA, 66.7% 
harbored iha, and 83.3% carried 7 or more pS88 related genes, revealing the potential of this 
serogroup as an etiological agent of severe infections. O80 is a serogroup that is difficult to type 
and may have gone under-detected and under-reported so far. Recently, however, O80:H2-
ST301-ξ has been reported associated with HUS and bacteremia in France (Soysal et al., 2016). 





We describe a collection of 95 clinical STEC strains based on O and H serotyping, multilocus 
sequence typing and molecular subtyping of virulence genes, including stx and eae subtyping 
and screening for subAB variants. STEC isolated during 2010-2014 were distinguished by the 
presence of O157:[H7|-ST11-1, O145:[H28/[H25]-ST32/ST342-1, O26:[H11]-ST21-1, 
O103:[H2]-ST20-and eae-negative O146:[H2/H28]-ST442/ST738 harboring subAB 
variants. Furthermore, we suggest that O80:[H2]ST-301-, an STEC that possesses a rare 
intimin variant and a high extraintestinal virulence potential due to the presence of plasmid 
pS88-associated genes is emerging in Switzerland. Continued efforts are required to elucidate 








Alonso CA, Mora A, Díaz D, Blanco M, González-Barrio D, Ruiz-Fons F. et al. (2017). 
Occurrence and characterization of stx and/or eae-positive Escherichia coli isolated from 
wildlife, including a typical EPEC strain from a wild boar. Vet Microbiol. 207: 69–73. 
 
Beutin L, Krause G, Zimmermann S, Kaulfuss S, Gleier K. (2004). Characterization of Shiga 
toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-
year period. J. Clin. Microbiol. 42: 1099–1108. 
 
Beutin L. (2006). Emerging enterohaemorrhagic Escherichia coli, causes and effects of the rise 
of a human pathogen. J Vet Med B Infect Dis Vet Public Health. 53:299-305. 
 
Beutin L, Delannoy S, Fach P. (2015). Genetic Diversity of the fliC genes encoding the flagellar 
antigen H19 of Escherichia coli and application to the specific identification of 
enterohemorrhagic E. coli O121: H19. Appl. Environ. Microbiol. 81:4224–4230. 
 
Bielaszewska M, Köck R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H et al. (2007). 
Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm. 
PLoS One 2:e1024. 
 
Bielaszewska M, Mellmann A, Bletz S, Zhang W, Köck R, Kossow A et al. (2013). 
Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin 
Infect Dis. 56:1373-1381. 
 
Blanco M, Schumacher S, Tasara T, Zweifel C, Blanco JE, Dahbi G. et al. (2005). Serotypes, 
intimin variants and other virulence factors of eae positive Escherichia coli strains isolated from 
healthy cattle in Switzerland. Identification of a new intimin variant gene (eae-η2). BMC 
Microbiol. 5:23. 
 
Bono JL, Smith TP, Keen JE, Harhay GP, McDaneld TG, Mandrell RE et al. (2012). Phylogeny 
of Shiga toxin-producing Escherichia coli O157 isolated from cattle and clinically ill humans. 
Mol Biol Evol. 29:2047-2062. 
 
DebRoy C, Fratamico PM, Yan X, Baranzoni G, Liu Y, Needleman D S et al. (2016). 
Comparison of O-antigen gene clusters of all O-Serogroups of Escherichia coli and proposal 
for adopting a new nomenclature for O-typing. PLoS One e0147434.  
 
European Centre for Disease Prevention and Control (ECDC). (2015). Surveillance of seven 
priority food- and waterborne diseases in the EU/EEA. Stockholm. 
 
European Food Safety Authority (EFSA) (2016). The European Union summary report on 
trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2015. EFSA J 
14:4634. 
 
European Union Reference Laboratory (EURL) (2013a). Identification and characterization of 
verocytotoxin-producing Escherichia coli (VTEC) by real time PCR amplification of the main 
virulence genes and the genes associated with the serogroups mainly associated with severe 
human infections. EU-RL VTEC_Method_02_Rev 0. 2013. Available at: 
13 
 
http://www.iss.it/binary/vtec/cont/EU_RL_VTEC_Method_02_Rev_0.pdf .  
 
European Union Reference Laboratory (EURL) (2013b). Detection and identification of 
verotoxin-producing Escherichia coli (VTEC) O104:H4 in food by real time PCR. EU-RL 
VTEC_Method_04_Rev 1.2013. Available at: Available at: 
http://www.iss.it/binary/vtec/cont/EU_RL_VTEC_Method_04_Rev_1.pdf 
 
European Union Reference Laboratory (EURL) (2013c). Detection of enterotoxigenic 
Escherichia coli in food by real time PCR amplification of the lt, sth, and stp genes, encoding 
the heat-labile and heat-stable enterotoxins. EU-RL VTEC_Method_08_Rev 0. 2013. Available 
at: http://www.iss.it/binary/vtec/cont/EU_RL_VTEC_Method_08_Rev_0.pdf. 
 
European Union Reference Laboratory (EURL) (2014). Identification of the VTEC serogroups 
mainly associated with human infections by conventional PCR amplification of O-associated 
genes. EU-RL VTEC_Method_03_Rev 01. 2014. Available at: 
http://www.iss.it/binary/vtec/cont/EU_RL_VTEC_Method_03_Rev_1.pdf 
 
Fasel D, Mellmann A, Cernela N, Hächler H, Fruth A, Khanna, N et al. (2014). Hemolytic 
uremic syndrome in a 65-year-old male linked to a very unusual type of stx2e- and eae-
harboring O51:H49 shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 52:1301–1303. 
 
Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A et al. (2002). 
Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical 
symptoms. J Infect Dis. 185:74-84. 
 
Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA. (2011). Shiga toxin subtypes display 
dramatic differences in potency. Infect Immun. 79:1329-1337. 
 
Funk J, Stoeber H, Hauser E, Schmidt H. (2013). Molecular analysis of subtilase cytotoxin 
genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB 
variant. BMC Microbiol. 13:230. 
 
Gannon VP, D’Souza S, Graham T, King RK, Rahn K, Read S. (1997). Use of the flagellar H7 
gene as a target in multiplex PCR assays and improved specificity in identification of 
enterohemorrhagic Escherichia coli strains. J Clin Microbiol. 35:656-662. 
 
Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, Garman KN et al. (2013). Increased 
recognition of non-O157 Shiga toxin–producing Escherichia coli infections in the United States 
during 2000–2010: epidemiologic features and comparison with E. coli O157 infections. 
Foodborne Pathog Dis. 10:453-460. 
 
Hoang Minh S, Kimura E, Hoang Minh D, Honjoh K, Miyamoto T. (2015). Virulence 
characteristics of Shiga toxin-producing Escherichia coli from raw meats and clinical samples. 
Microbiol Immunol. 59:114-122. 
 
Johnson KE, Thorpe CM, Sears CL. (2006). The emerging clinical importance of non-O157 
Shiga toxin-producing Escherichia coli. Clin Infect Dis. 43:1587-1595. 
 
Ju W, Cao G, Rump L, Strain E, Luo Y, Timme R et al. (2012). Phylogenetic analysis of non-





Käppeli U, Hächler H, Giezendanner N, Beutin L, Stephan R. (2011a). Human infections with 
non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000-2009. Emerg Infect Dis. 
17:180-185. 
 
Käppeli U, Hächler H, Giezendanner N, Cheasty T, Stephan R. (2011b). Shiga toxin-producing 
Escherichia coli O157 associated with human infections in Switzerland, 2000-2009. Epidemiol 
Infect. 139:1097-1104. 
 
Karch H, Tarr PI, Bielaszewska M. (2005). Enterohaemorrhagic Escherichia coli in human 
medicine. Int J Med Microbiol. 295:405-418. 
 
Khaitan A, Jandhyala DM, Thorpe CM, Ritchie JM, Paton AW. (2007). The operon encoding 
SubAB, a novel cytotoxin, is present in Shiga toxin-producing Escherichia coli isolates from 
the United States. J Clin Microbiol. 45:1374-1375. 
 
Kossow A, Zhang W, Bielaszewska M, Rhode S, Hansen K, Fruth A et al. (2016). Molecular 
characterization of human atypical sorbitol-fermenting enteropathogenic Escherichia coli O157 
reveals high diversity. J Clin Microbiol. 54:1357-1363. 
 
Mellmann A, Fruth A, Friedrich AW, Wieler LH, Harmsen D, Werber D et al. (2009). 
Phylogeny and disease association of Shiga toxin-producing Escherichia coli O91. Emerg 
Infect Dis. 15:1474-1477. 
 
Mora A, López C, Dhabi G, López-Beceiro AM, Fidalgo LE, Díaz, EA et al. (2012). 
Seropathotypes, phylogroups, Stx subtypes, and intimin types of wildlife-carried, shiga toxin-
producing Escherichia coli strains with the same characteristics as human-pathogenic isolates. 
Appl. Environ. Microbiol. 78:2578–2585. 
 
Müller A, Stephan R, Nüesch-Inderbinen M. (2016). Distribution of virulence factors in ESBL-
producing Escherichia coli isolated from the environment, livestock, food and humans. Sci 
Total Environ. 541:667-672. 
 
Nüesch-Inderbinen MT, Funk J, Cernela N, Tasara T, Klumpp J, Schmidt H et al. (2015). 
Prevalence of subtilase cytotoxin-encoding subAB variants among Shiga toxin-producing 
Escherichia coli strains isolated from wild ruminants and sheep differs from that of cattle and 
pigs and is predominated by the new allelic variant subAB2-2. Int J Med Microbiol. 305:124-
128. 
 
Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC. (2004). A new family of potent AB(5) 
cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med. 200:35-46. 
 
Peigne C, Bidet P, Mahjoub-Messai F, Plainvert C, Barbe V, Médigue C. et al. (2009). The 
plasmid of Escherichia coli strain S88 (O45: K1: H7) that causes neonatal meningitis is closely 
related to avian pathogenic E. coli plasmids and is associated with high-level bacteremia in a 
neonatal rat meningitis model. Infect. Immun. 77:2272–2284. 
 
Perelle S, Dilasser F, Grout J, Fach P. (2004). Detection by 5’-nuclease PCR of Shiga-toxin 
producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated 
15 
 
with the world’s most frequent clinical cases. Mol Cell Probes. 18:185-192. 
 
Scheutz F, Teel LD, Beutin L, Piérard D, Buvens G, Karch H et al. (2012). Multicenter 
evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx 
nomenclature. J Clin Microbiol. 50:2951-2963. 
 
Schmidt H, Knop C, Franke S, Aleksic S, Heesemann J, Karch H. (1995). Development of PCR 
for screening of enteroaggregative Escherichia coli. J. Clin. Microbiol. 33: 701–705. 
 
Schmidt, H, Zhang W-L, Hemmrich U, Jelacic S, Brunder W, Tarr PI. et al. (2001). 
Identification and characterization of a novel genomic island integrated at selC in locus of 
enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect. Iimmun. 69: 
6863–6873. 
 
Son HM, Duc HM, Honjoh K, Miyamoto T. (2015). Identification of the newly identified 
subtilase cytotoxin-encoding gene (subAB2-2) among clinical Shiga toxin-producing 
Escherichia coli isolates. Can J Microbiol. 61:990-994. 
 
Soysal N, Mariani-Kurkdjian P, Smail Y, Liguori S, Gouali M, Loukiadis E et al. (2016). 
Enterohemorrhagic Escherichia coli hybrid pathotype O80:H2 as a new therapeutic challenge. 
Emerg Infect Dis. 22:1604-1612. 
 
Stephan R, Hoelzle LE. (2000). Characterization of Shiga toxin type 2 variant B-subunit in 
Escherichia coli strains from asymptomatic human carriers by PCR-RFLP. Lett Appl Microbiol. 
31:139-142. 
 
Tasara T, Fierz, L., Klumpp, J., Schmidt, H., Stephan, R. (2017). Draft genome sequences of 
five Shiga toxin-producing Escherichia coli isolates harboring the new recently described 
subtilase cytotoxin allelic variant subAB2-3. Genome Announc. 5:e01582-16. 
 
Tozzoli, R, Caprioli A, Cappannella S, Michelacci V, Marziano ML, and Morabito S. (2010). 
Production of the subtilase AB5 cytotoxin by Shiga toxin-negative Escherichia coli. J. Clin. 
Microbiol. 48: 178–183. 
 
Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH et al. (2006). Sex and virulence in 
Escherichia coli: an evolutionary perspective. Mol Microbiol. 60:1136-1151. 
 
Zweifel C, Cernela N, Stephan R. (2013). Detection of the emerging Shiga toxin-producing 
Escherichia coli O26:H11/H- sequence type 29 (ST29) clone in human patients and healthy 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Firstly, I would like to express my sincere gratitude to my supervisor Prof. Dr. Dr. h.c. Roger 
Stephan for the opportunity to perform this doctoral thesis at the Institute for Food Safety and 
Hygiene at the University of Zurich. I am greatly indebted for his valuable discussions, support 
and his excellent guidance throughout my research.  
My sincere thanks also go to Nicole Cernela for her professional assistance in the laboratory 
work. Special thanks are due to Dr. Magdalena Nüesch-Inderbinen for her prompt and excellent 
help in the final touching the manuscript up. 
Furthermore, I would like to thank Dr. Elisabeth Hauser and her team at the National Reference 
Laboratory for Escherichia coli at the Federal Institute for Risk Assessment of Berlin (NRL-
E.coli, BfR) for their help in serotyping. 
Last but not least, I would like to thank the whole team at the Institute of Food Safety and 
Hygiene for their outstanding hospitality and professional support. It was great sharing the 









Heimatort Winterthur ZH 
08/2003 – 07/2007 Kantonsschule Büelrain Winterthur, Zürich, Schweiz 
31/08/2007 Erlangung der Maturität an der Kantonsschule Büelrain Winterthur 
Schwerpunkt Wirtschaft und Recht 
09/2009 – 12/2015 Studium der Veterinärmedizin an der Vetsuisse-Fakultät Universität 
Zürich, Schweiz 
30/12/2016 Erlangung des Tierärztediploms an der Vetsuisse-Fakultät Universität 
Zürich, Schweiz 
02/2016 – 07/2017 Anfertigung der Dissertation 
unter der Leitung von Prof. Dr. Dr. h.c. Roger Stephan 
am Institut für Lebensmittelsicherheit und -hygiene 
der Vetsuisse-Fakultät Universität Zürich 
Direktor: Prof. Dr. Dr. h.c. Roger Stephan 
02/2016 – 07/2017  Doktorandin, Institut für Lebensmittelsicherheit und -hygiene, 
  Zürich, Schweiz 
 
 
